ArticleInternational journal of nanomedicine2025
Combined Mulberry Leaf Polysaccharide-Caged Liposomes for Effective Oral Drug Delivery in Rat Model.
Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond Polysaccharides: Multifunctional Roles of Plant-Derived Conjugates in Sensory Enhancement and Food Quality Improvement.Comprehensive reviews in food science and food safety · 2026Review
- Fungal Polysaccharides as Modulators of Molecular Pathways in Liver Health.Molecules (Basel, Switzerland) · 2025Review
- Insights into the Activities and Usefulness of Deoxynojirimycin andMolecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Mulberry leaf polysaccharide (MLP) has gained attention as a potential anti-diabetic agent for lowering blood glucose and improving insulin sensitivity. However, the low gastrointestinal stability and oral bioavailability limit its clinical application. To address this issue, a novel drug-caged liposomes (MLP-CL) was developed to enhance oral delivery efficiency of MLP compared to conventional drug-encapsulated liposomes (MLP-L). Methods: MLP-L and MLP-CL were prepared by the thin-film hydration method. Subsequently, the structural integrity of these liposomes was assessed via in vitro release test and confocal laser microscopy (CLSM) analysis. Madin-Darby canine kidney (MDCK) cells were employed to investigate the cellular uptake mechanisms and transcellular transport efficiency. Finally, the biodistribution profiles and transport mechanisms of liposomes were evaluated through in vivo fluorescence imaging and pharmacokinetic studies in Sprague Dawley rats. Results: Compared to MLP-L, which released 80% of MLP within 4 hours, MLP-CL showed sustained release with only 40% released in the same period. MLP-CL also enabled more effective co-delivery of MLP and liposomes to MDCK cells, indicating improved structural integrity and cellular uptake. Transcellular transport assay confirmed that MLP-CL was transported across cells more efficiently. In vivo, MLP-CL increased intestinal accumulation and raised plasma MLP concentration by 50%. Additionally, by comparing the discrepancy between the lymphatic-suppression model and the normal model, it was found that 63.56% of MLP-CL was absorbed through the lymphatic pathway compared to 18.05% for MLP-L. Conclusion: Compared to conventional MLP-L, conjugation of polysaccharide improves the structural integrity of MLP-CL in the gastrointestinal tract, which in turn improves lymphatic uptake and bioavailability. This provides an effective strategy for the design of polysaccharide delivery systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.